DK319685A - Monoklonale antistoffer, fremgangsmaade til frembringelse af antistofferne, hybridomaceller, der producerer antistofferne, og anvendelse af antistofferne - Google Patents

Monoklonale antistoffer, fremgangsmaade til frembringelse af antistofferne, hybridomaceller, der producerer antistofferne, og anvendelse af antistofferne Download PDF

Info

Publication number
DK319685A
DK319685A DK319685A DK319685A DK319685A DK 319685 A DK319685 A DK 319685A DK 319685 A DK319685 A DK 319685A DK 319685 A DK319685 A DK 319685A DK 319685 A DK319685 A DK 319685A
Authority
DK
Denmark
Prior art keywords
antibodies
producing
procedures
hybridoma cells
monoclonal
Prior art date
Application number
DK319685A
Other languages
English (en)
Other versions
DK319685D0 (da
Inventor
Lars Saeegaard Nielsen
Peter Andre Andreasen
Keld Danae
Original Assignee
Fonden Til Fremme Af Eksperime
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8120155&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK319685(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fonden Til Fremme Af Eksperime filed Critical Fonden Til Fremme Af Eksperime
Priority to DK319685A priority Critical patent/DK319685A/da
Publication of DK319685D0 publication Critical patent/DK319685D0/da
Priority to EP19930202290 priority patent/EP0585995A1/en
Priority to JP61504151A priority patent/JPS63500564A/ja
Priority to AT86904118T priority patent/ATE103818T1/de
Priority to PCT/DK1986/000080 priority patent/WO1987000549A1/en
Priority to AU61446/86A priority patent/AU6144686A/en
Priority to EP86904118A priority patent/EP0229126B1/en
Priority to DE3689766T priority patent/DE3689766T2/de
Publication of DK319685A publication Critical patent/DK319685A/da
Priority to US07/900,364 priority patent/US5422245A/en
Priority to US08/466,965 priority patent/US6271352B1/en
Priority to US09/922,718 priority patent/US20020012950A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8132—Plasminogen activator inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • G01N2333/8121—Serpins
    • G01N2333/8132—Plasminogen activator inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK319685A 1985-07-12 1985-07-12 Monoklonale antistoffer, fremgangsmaade til frembringelse af antistofferne, hybridomaceller, der producerer antistofferne, og anvendelse af antistofferne DK319685A (da)

Priority Applications (11)

Application Number Priority Date Filing Date Title
DK319685A DK319685A (da) 1985-07-12 1985-07-12 Monoklonale antistoffer, fremgangsmaade til frembringelse af antistofferne, hybridomaceller, der producerer antistofferne, og anvendelse af antistofferne
DE3689766T DE3689766T2 (de) 1985-07-12 1986-07-11 Monoklonaler antikörper-inhibitor des plasminogenaktivators, hybridomen, herstellung monoklonaler antikörper und deren verwendung zur reinigung, beseitigung, inhibition oder zum testverfahren von inhibitoren.
EP86904118A EP0229126B1 (en) 1985-07-12 1986-07-11 Plasminogen activator inhibitor monoclonal antibodies, hybridomas, monoclonal antibody production and use of the antibodies for purification, removal, inhibition or assay of the inhibitors
AT86904118T ATE103818T1 (de) 1985-07-12 1986-07-11 Monoklonaler antikoerper-inhibitor des plasminogenaktivators, hybridomen, herstellung monoklonaler antikoerper und deren verwendung zur reinigung, beseitigung, inhibition oder zum testverfahren von inhibitoren.
JP61504151A JPS63500564A (ja) 1985-07-12 1986-07-11 モノクロ−ナル抗体
EP19930202290 EP0585995A1 (en) 1985-07-12 1986-07-11 Pure human endothelial type plasminogen activator inhibitor (e-PAI) and production thereof
PCT/DK1986/000080 WO1987000549A1 (en) 1985-07-12 1986-07-11 Plasminogen activator inhibitor monoclonal antibodies, hybridomas, monoclonal antibody production and use of the antibodies for purification, removal, inhibition or assay of the inhibitors
AU61446/86A AU6144686A (en) 1985-07-12 1986-07-11 Plasminogen activator inhibitor monoclonal antibodies, hybridomas, monoclonal antibody production and use of the antibodies for purification, removal, inhibition or assay of the inhibitors
US07/900,364 US5422245A (en) 1985-07-12 1992-06-18 Plasminogen activator inhibitor monoclonal antibodies, hybridomas, monoclonal antibody production and use of the antibodies for assay of the inhibitors
US08/466,965 US6271352B1 (en) 1985-07-12 1995-06-06 PAI-1 determination and use thereof
US09/922,718 US20020012950A1 (en) 1985-07-12 2001-08-07 Pai-1 determination and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK319685A DK319685A (da) 1985-07-12 1985-07-12 Monoklonale antistoffer, fremgangsmaade til frembringelse af antistofferne, hybridomaceller, der producerer antistofferne, og anvendelse af antistofferne

Publications (2)

Publication Number Publication Date
DK319685D0 DK319685D0 (da) 1985-07-12
DK319685A true DK319685A (da) 1987-01-13

Family

ID=8120155

Family Applications (1)

Application Number Title Priority Date Filing Date
DK319685A DK319685A (da) 1985-07-12 1985-07-12 Monoklonale antistoffer, fremgangsmaade til frembringelse af antistofferne, hybridomaceller, der producerer antistofferne, og anvendelse af antistofferne

Country Status (6)

Country Link
EP (1) EP0229126B1 (da)
JP (1) JPS63500564A (da)
AU (1) AU6144686A (da)
DE (1) DE3689766T2 (da)
DK (1) DK319685A (da)
WO (1) WO1987000549A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952512A (en) * 1984-06-22 1990-08-28 Loskutoff David J Gene encoding an inhibitor of tissue-type and urokinase-type plasminogen activators
US5102787A (en) * 1987-07-10 1992-04-07 Miho Sasamata Method, device and kit for measurement of tissue plasminogen activator activity
DE3742997A1 (de) * 1987-12-18 1989-06-29 Behringwerke Ag Peptide, verfahren zu ihrer herstellung, ihre verwendung zur gewinnung von antikoerpern sowie deren verwendung zur blockierung der pai-1-aktivitaet menschlichen blutes
JP2750732B2 (ja) * 1988-04-04 1998-05-13 帝人株式会社 ヒトプラスミノーゲンアクティベーターインヒビター・１−ヒト組織プラスミノーゲンアクティベーター複合体の免疫学的測定方法
NO891395L (no) * 1988-04-04 1989-10-05 Teijin Ltd Reagenssystem.
JP2868530B2 (ja) * 1989-04-03 1999-03-10 帝人株式会社 プラスミノーゲンアクティベーターインヒビターに対するモノクローナル抗体
AU652917B2 (en) * 1989-04-07 1994-09-15 Cancerforskningsfondet Af 1989 Urokinase-type plasminogen activator receptor
AU633366B2 (en) * 1989-10-02 1993-01-28 Teijin Limited Human tissue plasminogen activator-human plasminogen activator inhibitor complex immunoassay and kit therefor
DK85193D0 (da) * 1993-07-16 1993-07-16 Cancerforskningsfondet Af 1989 Suppression of inhibitors
SG10201710013RA (en) * 2013-08-13 2018-01-30 Sanofi Sa Antibodies to plasminogen activator inhibitor-1 (pai-1) and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE896543A (fr) * 1983-04-22 1983-08-16 Wallone Region Ensembles d'anticorps monoclonaux deriges contre les proteines humaines impliquees dans la coagulation et la fibrinolyse du sang
US4791068A (en) * 1984-06-22 1988-12-13 Scripps Clinic And Research Foundation Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators
EP0169549B1 (en) * 1984-07-26 1992-09-02 Teijin Limited Immunological determination of human plasmin/alpha2-plasmin inhibitor
US8127168B2 (en) * 2007-07-05 2012-02-28 Panasonic Corporation Data processing device for reducing power consumption while operating a virtualized environment, and a non-transitory computer-readable recording medium and integrated circuit for performing the same

Also Published As

Publication number Publication date
WO1987000549A1 (en) 1987-01-29
DE3689766T2 (de) 1994-12-01
AU6144686A (en) 1987-02-10
EP0229126A1 (en) 1987-07-22
EP0229126B1 (en) 1994-04-06
JPS63500564A (ja) 1988-03-03
DE3689766D1 (de) 1994-05-11
DK319685D0 (da) 1985-07-12

Similar Documents

Publication Publication Date Title
DK473887A (da) Hybridomacellelinie, monoklonalt antistof, fremgangsmaade til fremstilling af og anvendelse af det monoklonale antistof
DE3689734D1 (de) Gereinigter immunoglobulinbezüglicher Faktor, monoklonale Antikörper, Hybridoma-Zellinien, Verfahren und Verwendungen.
DK162171C (da) Monoklonale antistoffer, der er reaktive med eimeriaarters sporozoitters antigener, og fremgangsmaade til deres fremstilling
DK65185D0 (da) Fremgangsmaade til fremstilling af antistof
DK475389D0 (da) Fremgangsmaade til reduktion af monoklonale antistoffers heterogenitet
DK319685D0 (da) Monoklonale antistoffer, fremgangsmaade til frembringelse af antistofferne, hybridomaceller, der producerer antistofferne, og anvendelse af antistofferne
DK36482A (da) Fremgangsmaade til fremstilling af monoklonale antistoffer og celler,der er i stand til at producere saadanne antistoffer
DK188185D0 (da) Monoklonalt antistof
NO862920L (no) Onkofetale spesifikke monoklonale antistoffer, fremgangsmaate for fremstilling og anvendelse.
DK144485A (da) Monoklonale antistoffer
DK37785D0 (da) Monoclonalt antistof
DK651787D0 (da) A-associerede h-antigener, monoklonale antistoffer, der er specifikke heroverfor, og fremgangsmaader til anvendelse af disse til blodtypebestemmelse
DK673688A (da) Monoklone antistoffer, hybridom-cellelinier til f remstilling af antistofferne, fremgangsmaade til fremstilling af antistofferne og cellelinierne samt anvendelse af antistofferne
DK274882A (da) Fremgangsmaade til fremstilling af 4alfa,5alfa-epoxy-3,20-dioxopregnen-2alfa,16alfa-dicarbonitril og mellemprodukt herved
DK37382A (da) Fremgangsmaade til fremstilling af hybridceller,der producereret antistof,fremgangsmaade til fremstilling af antistoffer samt hybridceller og antistoffer
DK24891D0 (da) Monoklonalt antistof til inhibering af cellers infektion med hiv-vira
DK283883A (da) Fremgangsmaade, reagenssaet og apparat til paavisning af yverbetaendelse
DK494084D0 (da) Hybridoma, monokloniske antistoffer frembragt hermed og diagnosemetode under anvendelse af disse
DK557287A (da) Murin hybridoma lym-2, dermed fremstillet monoklonalt antistof og fremangsmaade til fremstilling af antistoffet
GB8816366D0 (en) Hybridoma cells & monoclonal antibodies
IL78871A0 (en) Monoclonal antibodies,hybridoma cell lines and their preparation
DK325183D0 (da) Mumane monoclonale antistoffer og lymfokiner
DK557187A (da) Murin hybridoma lym-1, dermed fremstillet monoklonalt antistof og fremgangsmaade til fremstilling af antistoffet
DK321687D0 (da) Monoklonalt antistof, dets fremstilling og anvendelse samt hybridomaceller til fremstillingen
DK514985D0 (da) For humane, planocellulaere lungecarcinomceller specifikke, monoklonale antistoffer, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment